Indivior Pharmaceuticals, Inc. (INDV) Operating cash flow 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$27.0MFY2025 · since FY2022: -$4.0M → -$27.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.0M | -175.0% |
| FY2024 | $36.0M | +112.0% |
| FY2023 | -$300.0M | -7400.0% |
| FY2022 | -$4.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice